| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 14,131,900 | 17,691,500 | 18,988,600 | | Cost of Revenue | 11,752,400 | 14,847,100 | 15,944,200 | | | Gross Profit | 2,379,500 | 2,844,400 | 3,044,400 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,827,000 | 2,047,900 | 2,165,000 | | Non Recurring | 1,756,500 |
-
|
-
| | Others | 90,800 | 91,700 | 82,900 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (1,294,800) | 704,800 | 796,500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 48,900 | 1,900 | 13,000 | | Earnings Before Interest And Taxes | (1,245,900) | 706,700 | 809,500 | | Interest Expense | 176,800 | 247,400 | 267,400 | | Income Before Tax | (1,422,700) | 459,300 | 542,100 | | Income Tax Expense | (197,300) | 171,300 | 210,700 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,225,400) | 288,000 | 331,400 | | | Non-recurring Events | | Discontinued Operations | (17,700) | (9,300) | (14,500) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,243,100) | 278,700 | 316,900 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,243,100) | $278,700 | $316,900 |
|
1.48% Nasdaq 
Income Statement
